DNA sequencing has mostly relied on machines from a single company, Illumina. However, this year, key patents protecting Illumina's sequencing technology will expire, paving the way for more competition.
Ultima Genomics has recently stated that it could provide human genomes for $100. With several other companies also promised faster, cheaper sequencing.
Read this article in Science for more details...